1-7 of 7
Naghmana Bajwa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of Ventricular Arrhythmias and Sudden Death with Acalabrutinib from 5 Prospective Clinical Trials

Jeff P. Sharman, Paolo Ghia, Paulo Andre P. Palhares De Miranda, Naghmana Bajwa, Simon Rule, Bob Shaw, John F. Seymour
Journal: Blood
Blood (2023) 142 (Supplement 1): 4643.
https://doi.org/10.1182/blood-2023-174913
Published: 2023
Journal Articles

Cumulative Review of Hypertension in Patients with Chronic Lymphocytic Leukemia (CLL) and Other Hematologic Malignancies Treated with Acalabrutinib

Alessandra Ferrajoli, George Follows, Yotvat Marmor, Shogheeg Apkarian Bourjlian, Jack Roos, Naghmana Bajwa, Venkata Madhira, Kenji Nozaki, Paulo Andre P. Palhares De Miranda, Krish Patel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1917.
https://doi.org/10.1182/blood-2023-174727
Published: 2023
Journal Articles

Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial

Clinical Trials & Observations
John F. Seymour, John C. Byrd, Paolo Ghia, Arnon P. Kater, Asher Chanan-Khan, Richard R. Furman, Susan O’Brien, Jennifer R. Brown, Talha Munir, Anthony Mato, Stephan Stilgenbauer, Naghmana Bajwa, Paulo Miranda, Kara Higgins, Ellie John, Marianne de Borja, Wojciech Jurczak, Jennifer A. Woyach
Journal: Blood
Blood (2023) 142 (8): 687–699.
https://doi.org/10.1182/blood.2022018818
Published: 2023
Includes: Supplemental data
Journal Articles

Fitusiran, an RNAi Therapeutic Targeting Antithrombin to Restore Hemostatic Balance in Patients with Hemophilia a or B with or without Inhibitors: Management of Acute Bleeding Events

Steven Pipe, MD, Margaret V. Ragni, MD MPH, Claude Négrier, MD PhD, Qifeng Yu, PhD, Naghmana Bajwa, MD, John Caminis, MD, Baisong Mei, MD PhD, Shauna R. Andersson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1138.
https://doi.org/10.1182/blood-2019-124108
Published: 2019
Journal Articles

Rationale for and Design of a Tolerability and Safety Study of FEIBA Reconstituted in Regular or 50% Reduced Volume and Faster Infusion Rates in Patients with Hemophilia A or B with Inhibitors

Talaha Mubarak Ali, Naghmana Bajwa
Journal: Blood
Blood (2017) 130 (Supplement 1): 4886.
https://doi.org/10.1182/blood.V130.Suppl_1.4886.4886
Published: 2017
Journal Articles

United States Post-Marketing Safety (PMS) Study of rpFVIII in Patients with Acquired Hemophilia A: Preliminary Data

R. Crea, DVM, MSc, Jui-Fu Huang, Naghmana Bajwa, Alessandro Gringeri, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3686.
https://doi.org/10.1182/blood.V130.Suppl_1.3686.3686
Published: 2017
Journal Articles

Four Decade Cumulative Review of Thrombo-Embolic Events Reported with the Use of Activated Prothrombin Complex Concentrate in Congenital Haemophilia

Roberto Crea, DVM, MSc, Aaron Novack, Armin J Reininger, Justine Kennedy, Sandra Raff, Alessandro Gringeri, MD MSc, Naghmana Bajwa
Journal: Blood
Blood (2016) 128 (22): 5031.
https://doi.org/10.1182/blood.V128.22.5031.5031
Published: 2016